Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This was posted by hptaxis at another board.
http://www.nytimes.com/2012/07/15/us/fda-surveillance-of-scientists-spread-to-outside-critics.html?_r=1
LOL
I am thinking of renaming one of my children Aria. And I have two boys LOL
If you stay the course, you will be eating steak at the table soon IMHO. Many here have gone thorugh many highs and lows with ARIAD. One I spoke of in post post# 20383. That was nerve racking. You will feel much more at ease once your position gets to double digits profit. I'm up almost 400% on my orginal entry. I do understand where your comming from.
I do wonder what will occur as ponatnib trials end and the new imformation on 113 begins to come to light. Im sure it will be a roller coaster.
BOD
Just another HO HUM Day (LOL)
Take a look at the daily chart for 5-19-2011 They took the PPS way down on a raid. Cant remember how much the drove the price down but I think it was around 40% and it happened fast. I was able to grab some on the way back up. I had to go through my PMs to find the date, I think this is the correct date, if not its very close to it. Wouldn't suprise me if it happened again sometime in the future.
Good Buy, its already in the green.
On 8500 shares it is not even cost effective with a round trip costing $14.00. They could have a few free trades though?
Good Trade, I purchased in low 17s yesterday. Didnt think it would make it down to the 16s again. These are trading shares, still holding a pile from the 3s in core position.
Heres the link to pcrutch orginal post.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77392573
My apologies. The Cramer link was inaccurate on my part! not that much he has to say is much more than FWIW. I timed out and could not edit the link.
My apologies once again for the error.
BOD
NAVB holding very well in the market down turn. I suspect they will receive FDA approval prior to Sept. 10, 2012.
This was written by pcruch. Something to think about on the FDA decision on AMRN.
This meeting certainly has bearish consequences. Given the high level FDA'ers present and Amarin's slew of lawyers & execs, I would be willing to bet that FDA rejected NCE and Amarin demanded a meeting to discuss why or lobby harder for it. Tough to spin this positively
I've talked with some about Amarin's patents and they really didnt see them as a huge barrier. Some of Amarin's patents say no DHA, well what if an analytical chemist at Teva finds 0.01%? Also, there is a ton of prior art out there from Epadel for someone to challenge Amarin's patents.
Some head honcho from the FDA at AMRN meeting :
E Dickinson, Esq.; FDA Chief Counsel;
Jay Sitlani, FDA, Regulatory Counsel.
K Webber, FDA Dir of Pharma Sci;
D Esposito, FDA Deputy Director - Office of Regulatory Policy;
E Coleman, FDA Deputy Director, Metabolism Division;
C Rosenbraugh, FDA Director Office of Drug Evaluation II;
K Johnson, FDA, Regulatory Project Manager;
M Unlu, FDA Gen'l Attorney;
K Dettlebach, FDA, Gen'l Attorney;
Here is Cramers take on AMRN, take it for what its worth:
http://money.msn.com/top-stocks/post.aspx?post=26a0b63a-1355-4fa4-9d6f-ea39010daba1
Looks like not much has changed here. PPS still falling, Cranshire still selling every share they get for a clear profit. They made a deal that keeps on giving...... Flash how many shares did they get in the reset? So many I cant even remember.
Im really not expecting any new news until Sept. 2012.
I picked up a block of shares here on the dip. No stop loss on this one!
MAKO getting hammered with at 40% loss today. This stock was at $45 not long ago.
http://news.morningstar.com/all/ViewNews.aspx?article=/ACQ/ff80808137790d1a0137cdeb416b1196_univ.xml
Another HO HUM day and a new 52 week high.
?
ALEXION is not even in the cancer space:
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on developing products for the treatment of diseases in the areas of hematology, nephrology, neurology, metabolic disorders, oncology, and ophthalmology. The company offers Soliris(eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), a blood disorder; and atypical hemolytic uremic syndrome (aHUS), an ultra-rare and life-threatening genetic disease. It also conducts Phase IV clinical trails on Soliris for its usage for the treatment of PNH registry, and aHUS for pediatric and adult. In addition, the company conducts various Phase II clinical trail programs on Soliris for its usage for the treatment of cold agglutinin disease; hemolytic uremic syndrome; dense deposit disease; presensitized renal transplant; ABO incompatible renal transplant; myasthenia gravis; neuromyelitis optica; and dry age-related macular degeneration. It is developing Asfotase alfa, a Phase II clinical trail program for the treatment of metabolic disorders, including hypophosphatasia; and Phase I clinical trail products comprising TT30 for hematology and Samalizumab for the treatment of oncology diseases, such as chronic lymphocytic leukemia and multiple myeloma. Further, the company conducts preclinical trails on cPMP for metabolic disorders. It serves specialty distributors and specialty pharmacies, which supply physician office clinics, hospital outpatient clinics, infusion clinics, or home health care providers; government agencies; and hospitals, hospital buying groups, pharmacies, other healthcare providers, and distributors. Alexion Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Cheshire, Connecticut.
Good move. Mine have gone there for quite some time now! About all I can say without the Bots deleting my post.
Not my first and I purchaced a few more on the second dip today with new funds? It could go lower, but time will tell, the markets are in turmoil.
NAVB on a steady climb. PDUFA date 10 Sept 2012. With the 90 day extenison this coud easiely get and early approval.Just ask yourself,wouldnt they give an extension for a longer time frame than needed, to insure they have enough time for any oversites? Shorts will scrambel to cover if it does!
With the 90 day extenison, I think an early approvel could easiely occur!
I think skip got a peek at the third "secret" product.
IMAGINE THAT, another secret from Mitch? was this on Facebook or a private email?
Did anyone see a PR or SEC filing on this, did I miss something?
What if the proxy vote count was not accurate? The counted it 2 times and filed an amended filing? Things that make you say WHAT?..............................
Quote:Dean will turn this around.... All he has to do is make the stock run.... History can repeat itself...
Ask yourself.... What is really different now than when the stock
Was trading at what 1.75 or s Jmho
I disssagree 100%.
You said it not me? Would you like to expand on your post?
If one was to cut to the chase I feel Dean Janes last 3 tax returns would tell a large story on what has occured with IMGG.
I welcome any input............................
Another nice day for NAVB Volume 817,714
Click on the link that appears when you attempt to log in. It will open your account. Everything is there with exception of Home Page. You can still trade.
Held up better than some, considering the markets.
It wont be long and any offer will have to be over the top. Let Pona get approved, postive results on 113 and an anouncment of another drug entering trials. You can place a serious X factor on the price for Ariad. Just my .02
Well, he will have pleanty of time to discuss that with Big John.
Maybe he could bring up "Cricket Stratgy" to change the subject during those awkard moments?
unless of course, a large pharma wants to make an offer...
If all would look at the HARVS share count and his net worth? Money is not his priority at this point in his life. The man is 62? IMO this is not his plan. He wants Ariad to be a standalone Pharmaceutical Company. He has stated this more than once. Selling the company is not in his vocabulary. JUST MY .02
I take him at his word.
BOD
Slightely different Gleen in his EYE, than the photo with the players wife "THE BLOND" in his lap?
Good Luck Allen
You need it.
A Crook at the top of his Game?
The SEC can’t serve Justice on every Crook. Sometimes it comes from unlikely places: This is graphic, not to be viewed by those with weak stomachs!
http://www.dailymail.co.uk/news/article-1327421/Allen-Stanford-beaten-jail-inmates-awaits-trial.html
BTH
I agree. I think your statment goes hand in hand with this portion of mejs post: IMHO the Market is CROOKED
BTW, IMO, the stock will probably be way up before the general public realizes 113 is working
Any where there is money involved, there will be those that are Crooked. I accept this fact. I wish the SEC could do more, but it is much better here than in other countries for now.
Anyone catch the blurb on Allen Stanford? Sometimes they reap what they soe?
http://www.dailymail.co.uk/news/article-1327421/Allen-Stanford-beaten-jail-inmates-awaits-trial.html
BOD
A lot of cash has been moving into NAVB in the last week. Holding the PPS well, Even as some take profits. The large volume will take care of the PPS IMO. They go Hand in Hand….. and the volume is there.
“My motto is there is never a bad time to take profits"
I have not taken any at this time. NAVB is on a nice run. It should take a breather soon and consolidate IMO. I think it goes much higher in the longer term baring an EU collapse.
The trials are public and at a 99% accuracy rate with no fatalities, I don’t see any way the FDA won’t approve this compound.
But then again, it is the US FDA, anything can happen.
BOD
Great post Bell.